Yukon government releases webpage with resources on long COVID
08 December 2022
The Yukon government acknowledged long COVID exists in a wide range of diverse and long-term effects in some people who have been infected with COVID-19 when it announced the creation of a long COVID working group. The Yukon government released a webpage that contains resources for Yukoners with symptoms of long COVID; for their friends and families; and for health-care providers.
A clinical trial for low dose naltrexone, which ends in December, is being run out of the Complex Chronic Diseases Program at B.C. Women’s Hospital and the post-COVID-19 recovery clinics in British Columbia. In the study description, Naltrexone could help to reduce pain and inflammation and improve well-being and immune function. The study is intended to demonstrate whether low doses of the drug could benefit a large number of people with post-COVID fatigue syndrome.